1 Non-prescription Mouthrinse Market Overview 1.1 Product Overview and Scope of Non-prescription Mouthrinse 1.2 Non-prescription Mouthrinse Segment by Type 1.2.1 Global Non-prescription Mouthrinse Market Value Comparison by Type (2023-2029) 1.2.2 Alcoholic 1.2.3 Non-alcoholic 1.3 Non-prescription Mouthrinse Segment by Application 1.3.1 Global Non-prescription Mouthrinse Market Value by Application: (2023-2029) 1.3.2 Hypermarket and Supermarket 1.3.3 Convenience Stores 1.3.4 Online Sale 1.4 Global Non-prescription Mouthrinse Market Size Estimates and Forecasts 1.4.1 Global Non-prescription Mouthrinse Revenue 2018-2029 1.4.2 Global Non-prescription Mouthrinse Sales 2018-2029 1.4.3 Global Non-prescription Mouthrinse Market Average Price (2018-2029) 1.5 Assumptions and Limitations 2 Non-prescription Mouthrinse Market Competition by Manufacturers 2.1 Global Non-prescription Mouthrinse Sales Market Share by Manufacturers (2018-2023) 2.2 Global Non-prescription Mouthrinse Revenue Market Share by Manufacturers (2018-2023) 2.3 Global Non-prescription Mouthrinse Average Price by Manufacturers (2018-2023) 2.4 Global Non-prescription Mouthrinse Industry Ranking 2021 VS 2022 VS 2023 2.5 Global Key Manufacturers of Non-prescription Mouthrinse, Manufacturing Sites & Headquarters 2.6 Global Key Manufacturers of Non-prescription Mouthrinse, Product Type & Application 2.7 Non-prescription Mouthrinse Market Competitive Situation and Trends 2.7.1 Non-prescription Mouthrinse Market Concentration Rate 2.7.2 The Global Top 5 and Top 10 Largest Non-prescription Mouthrinse Players Market Share by Revenue 2.7.3 Global Non-prescription Mouthrinse Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.8 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Non-prescription Mouthrinse Retrospective Market Scenario by Region 3.1 Global Non-prescription Mouthrinse Market Size by Region: 2018 Versus 2022 Versus 2029 3.2 Global Non-prescription Mouthrinse Global Non-prescription Mouthrinse Sales by Region: 2018-2029 3.2.1 Global Non-prescription Mouthrinse Sales by Region: 2018-2023 3.2.2 Global Non-prescription Mouthrinse Sales by Region: 2024-2029 3.3 Global Non-prescription Mouthrinse Global Non-prescription Mouthrinse Revenue by Region: 2018-2029 3.3.1 Global Non-prescription Mouthrinse Revenue by Region: 2018-2023 3.3.2 Global Non-prescription Mouthrinse Revenue by Region: 2024-2029 3.4 North America Non-prescription Mouthrinse Market Facts & Figures by Country 3.4.1 North America Non-prescription Mouthrinse Market Size by Country: 2018 VS 2022 VS 2029 3.4.2 North America Non-prescription Mouthrinse Sales by Country (2018-2029) 3.4.3 North America Non-prescription Mouthrinse Revenue by Country (2018-2029) 3.4.4 U.S. 3.4.5 Canada 3.5 Europe Non-prescription Mouthrinse Market Facts & Figures by Country 3.5.1 Europe Non-prescription Mouthrinse Market Size by Country: 2018 VS 2022 VS 2029 3.5.2 Europe Non-prescription Mouthrinse Sales by Country (2018-2029) 3.5.3 Europe Non-prescription Mouthrinse Revenue by Country (2018-2029) 3.5.4 Germany 3.5.5 France 3.5.6 U.K. 3.5.7 Italy 3.5.8 Russia 3.6 Asia Pacific Non-prescription Mouthrinse Market Facts & Figures by Country 3.6.1 Asia Pacific Non-prescription Mouthrinse Market Size by Country: 2018 VS 2022 VS 2029 3.6.2 Asia Pacific Non-prescription Mouthrinse Sales by Country (2018-2029) 3.6.3 Asia Pacific Non-prescription Mouthrinse Revenue by Country (2018-2029) 3.6.4 China 3.6.5 Japan 3.6.6 South Korea 3.6.7 India 3.6.8 Australia 3.6.9 Taiwan 3.6.10 Indonesia 3.6.11 Thailand 3.6.12 Malaysia 3.6.13 Philippines 3.7 Latin America Non-prescription Mouthrinse Market Facts & Figures by Country 3.7.1 Latin America Non-prescription Mouthrinse Market Size by Country: 2018 VS 2022 VS 2029 3.7.2 Latin America Non-prescription Mouthrinse Sales by Country (2018-2029) 3.7.3 Latin America Non-prescription Mouthrinse Revenue by Country (2018-2029) 3.7.4 Mexico 3.7.5 Brazil 3.7.6 Argentina 3.8 Middle East and Africa Non-prescription Mouthrinse Market Facts & Figures by Country 3.8.1 Middle East and Africa Non-prescription Mouthrinse Market Size by Country: 2018 VS 2022 VS 2029 3.8.2 Middle East and Africa Non-prescription Mouthrinse Sales by Country (2018-2029) 3.8.3 Middle East and Africa Non-prescription Mouthrinse Revenue by Country (2018-2029) 3.8.4 Turkey 3.8.5 Saudi Arabia 3.8.6 U.A.E 4 Segment by Type 4.1 Global Non-prescription Mouthrinse Sales by Type (2018-2029) 4.1.1 Global Non-prescription Mouthrinse Sales by Type (2018-2023) 4.1.2 Global Non-prescription Mouthrinse Sales by Type (2024-2029) 4.1.3 Global Non-prescription Mouthrinse Sales Market Share by Type (2018-2029) 4.2 Global Non-prescription Mouthrinse Revenue by Type (2018-2029) 4.2.1 Global Non-prescription Mouthrinse Revenue by Type (2018-2023) 4.2.2 Global Non-prescription Mouthrinse Revenue by Type (2024-2029) 4.2.3 Global Non-prescription Mouthrinse Revenue Market Share by Type (2018-2029) 4.3 Global Non-prescription Mouthrinse Price by Type (2018-2029) 5 Segment by Application 5.1 Global Non-prescription Mouthrinse Sales by Application (2018-2029) 5.1.1 Global Non-prescription Mouthrinse Sales by Application (2018-2023) 5.1.2 Global Non-prescription Mouthrinse Sales by Application (2024-2029) 5.1.3 Global Non-prescription Mouthrinse Sales Market Share by Application (2018-2029) 5.2 Global Non-prescription Mouthrinse Revenue by Application (2018-2029) 5.2.1 Global Non-prescription Mouthrinse Revenue by Application (2018-2023) 5.2.2 Global Non-prescription Mouthrinse Revenue by Application (2024-2029) 5.2.3 Global Non-prescription Mouthrinse Revenue Market Share by Application (2018-2029) 5.3 Global Non-prescription Mouthrinse Price by Application (2018-2029) 6 Key Companies Profiled 6.1 Johnson & Johnson 6.1.1 Johnson & Johnson Corporation Information 6.1.2 Johnson & Johnson Description and Business Overview 6.1.3 Johnson & Johnson Non-prescription Mouthrinse Sales, Revenue and Gross Margin (2018-2023) 6.1.4 Johnson & Johnson Non-prescription Mouthrinse Product Portfolio 6.1.5 Johnson & Johnson Recent Developments/Updates 6.2 Sunstar 6.2.1 Sunstar Corporation Information 6.2.2 Sunstar Description and Business Overview 6.2.3 Sunstar Non-prescription Mouthrinse Sales, Revenue and Gross Margin (2018-2023) 6.2.4 Sunstar Non-prescription Mouthrinse Product Portfolio 6.2.5 Sunstar Recent Developments/Updates 6.3 P&G 6.3.1 P&G Corporation Information 6.3.2 P&G Description and Business Overview 6.3.3 P&G Non-prescription Mouthrinse Sales, Revenue and Gross Margin (2018-2023) 6.3.4 P&G Non-prescription Mouthrinse Product Portfolio 6.3.5 P&G Recent Developments/Updates 6.4 Lion 6.4.1 Lion Corporation Information 6.4.2 Lion Description and Business Overview 6.4.3 Lion Non-prescription Mouthrinse Sales, Revenue and Gross Margin (2018-2023) 6.4.4 Lion Non-prescription Mouthrinse Product Portfolio 6.4.5 Lion Recent Developments/Updates 6.5 Colgate-Palmolive 6.5.1 Colgate-Palmolive Corporation Information 6.5.2 Colgate-Palmolive Description and Business Overview 6.5.3 Colgate-Palmolive Non-prescription Mouthrinse Sales, Revenue and Gross Margin (2018-2023) 6.5.4 Colgate-Palmolive Non-prescription Mouthrinse Product Portfolio 6.5.5 Colgate-Palmolive Recent Developments/Updates 6.6 Unilever 6.6.1 Unilever Corporation Information 6.6.2 Unilever Description and Business Overview 6.6.3 Unilever Non-prescription Mouthrinse Sales, Revenue and Gross Margin (2018-2023) 6.6.4 Unilever Non-prescription Mouthrinse Product Portfolio 6.6.5 Unilever Recent Developments/Updates 6.7 Church & Dwight 6.6.1 Church & Dwight Corporation Information 6.6.2 Church & Dwight Description and Business Overview 6.6.3 Church & Dwight Non-prescription Mouthrinse Sales, Revenue and Gross Margin (2018-2023) 6.4.4 Church & Dwight Non-prescription Mouthrinse Product Portfolio 6.7.5 Church & Dwight Recent Developments/Updates 6.8 PIERAS CO 6.8.1 PIERAS CO Corporation Information 6.8.2 PIERAS CO Description and Business Overview 6.8.3 PIERAS CO Non-prescription Mouthrinse Sales, Revenue and Gross Margin (2018-2023) 6.8.4 PIERAS CO Non-prescription Mouthrinse Product Portfolio 6.8.5 PIERAS CO Recent Developments/Updates 6.9 GSK 6.9.1 GSK Corporation Information 6.9.2 GSK Description and Business Overview 6.9.3 GSK Non-prescription Mouthrinse Sales, Revenue and Gross Margin (2018-2023) 6.9.4 GSK Non-prescription Mouthrinse Product Portfolio 6.9.5 GSK Recent Developments/Updates 6.10 Caldwell Consumer Health 6.10.1 Caldwell Consumer Health Corporation Information 6.10.2 Caldwell Consumer Health Description and Business Overview 6.10.3 Caldwell Consumer Health Non-prescription Mouthrinse Sales, Revenue and Gross Margin (2018-2023) 6.10.4 Caldwell Consumer Health Non-prescription Mouthrinse Product Portfolio 6.10.5 Caldwell Consumer Health Recent Developments/Updates 6.11 Weleda 6.11.1 Weleda Corporation Information 6.11.2 Weleda Non-prescription Mouthrinse Description and Business Overview 6.11.3 Weleda Non-prescription Mouthrinse Sales, Revenue and Gross Margin (2018-2023) 6.11.4 Weleda Non-prescription Mouthrinse Product Portfolio 6.11.5 Weleda Recent Developments/Updates 6.12 Dentyl Active 6.12.1 Dentyl Active Corporation Information 6.12.2 Dentyl Active Non-prescription Mouthrinse Description and Business Overview 6.12.3 Dentyl Active Non-prescription Mouthrinse Sales, Revenue and Gross Margin (2018-2023) 6.12.4 Dentyl Active Non-prescription Mouthrinse Product Portfolio 6.12.5 Dentyl Active Recent Developments/Updates 6.13 Kao Corporation 6.13.1 Kao Corporation Corporation Information 6.13.2 Kao Corporation Non-prescription Mouthrinse Description and Business Overview 6.13.3 Kao Corporation Non-prescription Mouthrinse Sales, Revenue and Gross Margin (2018-2023) 6.13.4 Kao Corporation Non-prescription Mouthrinse Product Portfolio 6.13.5 Kao Corporation Recent Developments/Updates 6.14 NYSCPS 6.14.1 NYSCPS Corporation Information 6.14.2 NYSCPS Non-prescription Mouthrinse Description and Business Overview 6.14.3 NYSCPS Non-prescription Mouthrinse Sales, Revenue and Gross Margin (2018-2023) 6.14.4 NYSCPS Non-prescription Mouthrinse Product Portfolio 6.14.5 NYSCPS Recent Developments/Updates 6.15 WEIMEIZI (GUANGDONG) CO. 6.15.1 WEIMEIZI (GUANGDONG) CO. Corporation Information 6.15.2 WEIMEIZI (GUANGDONG) CO. Non-prescription Mouthrinse Description and Business Overview 6.15.3 WEIMEIZI (GUANGDONG) CO. Non-prescription Mouthrinse Sales, Revenue and Gross Margin (2018-2023) 6.15.4 WEIMEIZI (GUANGDONG) CO. Non-prescription Mouthrinse Product Portfolio 6.15.5 WEIMEIZI (GUANGDONG) CO. Recent Developments/Updates 7 Industry Chain and Sales Channels Analysis 7.1 Non-prescription Mouthrinse Industry Chain Analysis 7.2 Non-prescription Mouthrinse Key Raw Materials 7.2.1 Key Raw Materials 7.2.2 Raw Materials Key Suppliers 7.3 Non-prescription Mouthrinse Production Mode & Process 7.4 Non-prescription Mouthrinse Sales and Marketing 7.4.1 Non-prescription Mouthrinse Sales Channels 7.4.2 Non-prescription Mouthrinse Distributors 7.5 Non-prescription Mouthrinse Customers 8 Non-prescription Mouthrinse Market Dynamics 8.1 Non-prescription Mouthrinse Industry Trends 8.2 Non-prescription Mouthrinse Market Drivers 8.3 Non-prescription Mouthrinse Market Challenges 8.4 Non-prescription Mouthrinse Market Restraints 9 Research Finding and Conclusion 10 Methodology and Data Source 10.1 Methodology/Research Approach 10.1.1 Research Programs/Design 10.1.2 Market Size Estimation 10.1.3 Market Breakdown and Data Triangulation 10.2 Data Source 10.2.1 Secondary Sources 10.2.2 Primary Sources 10.3 Author List 10.4 Disclaimer

List of Tables Table 1. Global Non-prescription Mouthrinse Market Value Comparison by Type (2023-2029) & (US$ Million) Table 2. Global Non-prescription Mouthrinse Market Value Comparison by Application (2023-2029) & (US$ Million) Table 3. Global Non-prescription Mouthrinse Market Competitive Situation by Manufacturers in 2022 Table 4. Global Non-prescription Mouthrinse Sales (K Units) of Key Manufacturers (2018-2023) Table 5. Global Non-prescription Mouthrinse Sales Market Share by Manufacturers (2018-2023) Table 6. Global Non-prescription Mouthrinse Revenue (US$ Million) by Manufacturers (2018-2023) Table 7. Global Non-prescription Mouthrinse Revenue Share by Manufacturers (2018-2023) Table 8. Global Market Non-prescription Mouthrinse Average Price (US$/Unit) of Key Manufacturers (2018-2023) Table 9. Global Key Players of Non-prescription Mouthrinse, Industry Ranking, 2021 VS 2022 VS 2023 Table 10. Global Key Manufacturers of Non-prescription Mouthrinse, Manufacturing Sites & Headquarters Table 11. Global Key Manufacturers of Non-prescription Mouthrinse, Product Type & Application Table 12. Global Key Manufacturers of Non-prescription Mouthrinse, Date of Enter into This Industry Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 14. Global Non-prescription Mouthrinse by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-prescription Mouthrinse as of 2022) Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans Table 16. Global Non-prescription Mouthrinse Market Size by Region (US$ Million): 2018 VS 2022 VS 2029 Table 17. Global Non-prescription Mouthrinse Sales by Region (2018-2023) & (K Units) Table 18. Global Non-prescription Mouthrinse Sales Market Share by Region (2018-2023) Table 19. Global Non-prescription Mouthrinse Sales by Region (2024-2029) & (K Units) Table 20. Global Non-prescription Mouthrinse Sales Market Share by Region (2024-2029) Table 21. Global Non-prescription Mouthrinse Revenue by Region (2018-2023) & (US$ Million) Table 22. Global Non-prescription Mouthrinse Revenue Market Share by Region (2018-2023) Table 23. Global Non-prescription Mouthrinse Revenue by Region (2024-2029) & (US$ Million) Table 24. Global Non-prescription Mouthrinse Revenue Market Share by Region (2024-2029) Table 25. North America Non-prescription Mouthrinse Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million) Table 26. North America Non-prescription Mouthrinse Sales by Country (2018-2023) & (K Units) Table 27. North America Non-prescription Mouthrinse Sales by Country (2024-2029) & (K Units) Table 28. North America Non-prescription Mouthrinse Revenue by Country (2018-2023) & (US$ Million) Table 29. North America Non-prescription Mouthrinse Revenue by Country (2024-2029) & (US$ Million) Table 30. Europe Non-prescription Mouthrinse Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million) Table 31. Europe Non-prescription Mouthrinse Sales by Country (2018-2023) & (K Units) Table 32. Europe Non-prescription Mouthrinse Sales by Country (2024-2029) & (K Units) Table 33. Europe Non-prescription Mouthrinse Revenue by Country (2018-2023) & (US$ Million) Table 34. Europe Non-prescription Mouthrinse Revenue by Country (2024-2029) & (US$ Million) Table 35. Asia Pacific Non-prescription Mouthrinse Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million) Table 36. Asia Pacific Non-prescription Mouthrinse Sales by Region (2018-2023) & (K Units) Table 37. Asia Pacific Non-prescription Mouthrinse Sales by Region (2024-2029) & (K Units) Table 38. Asia Pacific Non-prescription Mouthrinse Revenue by Region (2018-2023) & (US$ Million) Table 39. Asia Pacific Non-prescription Mouthrinse Revenue by Region (2024-2029) & (US$ Million) Table 40. Latin America Non-prescription Mouthrinse Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million) Table 41. Latin America Non-prescription Mouthrinse Sales by Country (2018-2023) & (K Units) Table 42. Latin America Non-prescription Mouthrinse Sales by Country (2024-2029) & (K Units) Table 43. Latin America Non-prescription Mouthrinse Revenue by Country (2018-2023) & (US$ Million) Table 44. Latin America Non-prescription Mouthrinse Revenue by Country (2024-2029) & (US$ Million) Table 45. Middle East & Africa Non-prescription Mouthrinse Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million) Table 46. Middle East & Africa Non-prescription Mouthrinse Sales by Country (2018-2023) & (K Units) Table 47. Middle East & Africa Non-prescription Mouthrinse Sales by Country (2024-2029) & (K Units) Table 48. Middle East & Africa Non-prescription Mouthrinse Revenue by Country (2018-2023) & (US$ Million) Table 49. Middle East & Africa Non-prescription Mouthrinse Revenue by Country (2024-2029) & (US$ Million) Table 50. Global Non-prescription Mouthrinse Sales (K Units) by Type (2018-2023) Table 51. Global Non-prescription Mouthrinse Sales (K Units) by Type (2024-2029) Table 52. Global Non-prescription Mouthrinse Sales Market Share by Type (2018-2023) Table 53. Global Non-prescription Mouthrinse Sales Market Share by Type (2024-2029) Table 54. Global Non-prescription Mouthrinse Revenue (US$ Million) by Type (2018-2023) Table 55. Global Non-prescription Mouthrinse Revenue (US$ Million) by Type (2024-2029) Table 56. Global Non-prescription Mouthrinse Revenue Market Share by Type (2018-2023) Table 57. Global Non-prescription Mouthrinse Revenue Market Share by Type (2024-2029) Table 58. Global Non-prescription Mouthrinse Price (US$/Unit) by Type (2018-2023) Table 59. Global Non-prescription Mouthrinse Price (US$/Unit) by Type (2024-2029) Table 60. Global Non-prescription Mouthrinse Sales (K Units) by Application (2018-2023) Table 61. Global Non-prescription Mouthrinse Sales (K Units) by Application (2024-2029) Table 62. Global Non-prescription Mouthrinse Sales Market Share by Application (2018-2023) Table 63. Global Non-prescription Mouthrinse Sales Market Share by Application (2024-2029) Table 64. Global Non-prescription Mouthrinse Revenue (US$ Million) by Application (2018-2023) Table 65. Global Non-prescription Mouthrinse Revenue (US$ Million) by Application (2024-2029) Table 66. Global Non-prescription Mouthrinse Revenue Market Share by Application (2018-2023) Table 67. Global Non-prescription Mouthrinse Revenue Market Share by Application (2024-2029) Table 68. Global Non-prescription Mouthrinse Price (US$/Unit) by Application (2018-2023) Table 69. Global Non-prescription Mouthrinse Price (US$/Unit) by Application (2024-2029) Table 70. Johnson & Johnson Corporation Information Table 71. Johnson & Johnson Description and Business Overview Table 72. Johnson & Johnson Non-prescription Mouthrinse Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 73. Johnson & Johnson Non-prescription Mouthrinse Product Table 74. Johnson & Johnson Recent Developments/Updates Table 75. Sunstar Corporation Information Table 76. Sunstar Description and Business Overview Table 77. Sunstar Non-prescription Mouthrinse Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 78. Sunstar Non-prescription Mouthrinse Product Table 79. Sunstar Recent Developments/Updates Table 80. P&G Corporation Information Table 81. P&G Description and Business Overview Table 82. P&G Non-prescription Mouthrinse Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 83. P&G Non-prescription Mouthrinse Product Table 84. P&G Recent Developments/Updates Table 85. Lion Corporation Information Table 86. Lion Description and Business Overview Table 87. Lion Non-prescription Mouthrinse Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 88. Lion Non-prescription Mouthrinse Product Table 89. Lion Recent Developments/Updates Table 90. Colgate-Palmolive Corporation Information Table 91. Colgate-Palmolive Description and Business Overview Table 92. Colgate-Palmolive Non-prescription Mouthrinse Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 93. Colgate-Palmolive Non-prescription Mouthrinse Product Table 94. Colgate-Palmolive Recent Developments/Updates Table 95. Unilever Corporation Information Table 96. Unilever Description and Business Overview Table 97. Unilever Non-prescription Mouthrinse Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 98. Unilever Non-prescription Mouthrinse Product Table 99. Unilever Recent Developments/Updates Table 100. Church & Dwight Corporation Information Table 101. Church & Dwight Description and Business Overview Table 102. Church & Dwight Non-prescription Mouthrinse Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 103. Church & Dwight Non-prescription Mouthrinse Product Table 104. Church & Dwight Recent Developments/Updates Table 105. PIERAS CO Corporation Information Table 106. PIERAS CO Description and Business Overview Table 107. PIERAS CO Non-prescription Mouthrinse Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 108. PIERAS CO Non-prescription Mouthrinse Product Table 109. PIERAS CO Recent Developments/Updates Table 110. GSK Corporation Information Table 111. GSK Description and Business Overview Table 112. GSK Non-prescription Mouthrinse Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 113. GSK Non-prescription Mouthrinse Product Table 114. GSK Recent Developments/Updates Table 115. Caldwell Consumer Health Corporation Information Table 116. Caldwell Consumer Health Description and Business Overview Table 117. Caldwell Consumer Health Non-prescription Mouthrinse Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 118. Caldwell Consumer Health Non-prescription Mouthrinse Product Table 119. Caldwell Consumer Health Recent Developments/Updates Table 120. Weleda Corporation Information Table 121. Weleda Description and Business Overview Table 122. Weleda Non-prescription Mouthrinse Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 123. Weleda Non-prescription Mouthrinse Product Table 124. Weleda Recent Developments/Updates Table 125. Dentyl Active Corporation Information Table 126. Dentyl Active Description and Business Overview Table 127. Dentyl Active Non-prescription Mouthrinse Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 128. Dentyl Active Non-prescription Mouthrinse Product Table 129. Dentyl Active Recent Developments/Updates Table 130. Kao Corporation Corporation Information Table 131. Kao Corporation Description and Business Overview Table 132. Kao Corporation Non-prescription Mouthrinse Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 133. Kao Corporation Non-prescription Mouthrinse Product Table 134. Kao Corporation Recent Developments/Updates Table 135. NYSCPS Corporation Information Table 136. NYSCPS Description and Business Overview Table 137. NYSCPS Non-prescription Mouthrinse Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 138. NYSCPS Non-prescription Mouthrinse Product Table 139. NYSCPS Recent Developments/Updates Table 140. WEIMEIZI (GUANGDONG) CO. Corporation Information Table 141. WEIMEIZI (GUANGDONG) CO. Description and Business Overview Table 142. WEIMEIZI (GUANGDONG) CO. Non-prescription Mouthrinse Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 143. WEIMEIZI (GUANGDONG) CO. Non-prescription Mouthrinse Product Table 144. WEIMEIZI (GUANGDONG) CO. Recent Developments/Updates Table 145. Key Raw Materials Lists Table 146. Raw Materials Key Suppliers Lists Table 147. Non-prescription Mouthrinse Distributors List Table 148. Non-prescription Mouthrinse Customers List Table 149. Non-prescription Mouthrinse Market Trends Table 150. Non-prescription Mouthrinse Market Drivers Table 151. Non-prescription Mouthrinse Market Challenges Table 152. Non-prescription Mouthrinse Market Restraints Table 153. Research Programs/Design for This Report Table 154. Key Data Information from Secondary Sources Table 155. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Non-prescription Mouthrinse Figure 2. Global Non-prescription Mouthrinse Market Value Comparison by Type (2023-2029) & (US$ Million) Figure 3. Global Non-prescription Mouthrinse Market Share by Type in 2022 & 2029 Figure 4. Alcoholic Product Picture Figure 5. Non-alcoholic Product Picture Figure 6. Global Non-prescription Mouthrinse Market Value Comparison by Application (2023-2029) & (US$ Million) Figure 7. Global Non-prescription Mouthrinse Market Share by Application in 2022 & 2029 Figure 8. Hypermarket and Supermarket Figure 9. Convenience Stores Figure 10. Online Sale Figure 11. Global Non-prescription Mouthrinse Revenue, (US$ Million), 2018 VS 2022 VS 2029 Figure 12. Global Non-prescription Mouthrinse Market Size (2018-2029) & (US$ Million) Figure 13. Global Non-prescription Mouthrinse Sales (2018-2029) & (K Units) Figure 14. Global Non-prescription Mouthrinse Average Price (US$/Unit) & (2018-2029) Figure 15. Non-prescription Mouthrinse Report Years Considered Figure 16. Non-prescription Mouthrinse Sales Share by Manufacturers in 2022 Figure 17. Global Non-prescription Mouthrinse Revenue Share by Manufacturers in 2022 Figure 18. The Global 5 and 10 Largest Non-prescription Mouthrinse Players: Market Share by Revenue in 2022 Figure 19. Non-prescription Mouthrinse Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022 Figure 20. Global Non-prescription Mouthrinse Market Size by Region (US$ Million): 2018 VS 2022 VS 2029 Figure 21. North America Non-prescription Mouthrinse Sales Market Share by Country (2018-2029) Figure 22. North America Non-prescription Mouthrinse Revenue Market Share by Country (2018-2029) Figure 23. U.S. Non-prescription Mouthrinse Revenue Growth Rate (2018-2029) & (US$ Million) Figure 24. Canada Non-prescription Mouthrinse Revenue Growth Rate (2018-2029) & (US$ Million) Figure 25. Europe Non-prescription Mouthrinse Sales Market Share by Country (2018-2029) Figure 26. Europe Non-prescription Mouthrinse Revenue Market Share by Country (2018-2029) Figure 27. Germany Non-prescription Mouthrinse Revenue Growth Rate (2018-2029) & (US$ Million) Figure 28. France Non-prescription Mouthrinse Revenue Growth Rate (2018-2029) & (US$ Million) Figure 29. U.K. Non-prescription Mouthrinse Revenue Growth Rate (2018-2029) & (US$ Million) Figure 30. Italy Non-prescription Mouthrinse Revenue Growth Rate (2018-2029) & (US$ Million) Figure 31. Russia Non-prescription Mouthrinse Revenue Growth Rate (2018-2029) & (US$ Million) Figure 32. Asia Pacific Non-prescription Mouthrinse Sales Market Share by Region (2018-2029) Figure 33. Asia Pacific Non-prescription Mouthrinse Revenue Market Share by Region (2018-2029) Figure 34. China Non-prescription Mouthrinse Revenue Growth Rate (2018-2029) & (US$ Million) Figure 35. Japan Non-prescription Mouthrinse Revenue Growth Rate (2018-2029) & (US$ Million) Figure 36. South Korea Non-prescription Mouthrinse Revenue Growth Rate (2018-2029) & (US$ Million) Figure 37. India Non-prescription Mouthrinse Revenue Growth Rate (2018-2029) & (US$ Million) Figure 38. Australia Non-prescription Mouthrinse Revenue Growth Rate (2018-2029) & (US$ Million) Figure 39. Taiwan Non-prescription Mouthrinse Revenue Growth Rate (2018-2029) & (US$ Million) Figure 40. Indonesia Non-prescription Mouthrinse Revenue Growth Rate (2018-2029) & (US$ Million) Figure 41. Thailand Non-prescription Mouthrinse Revenue Growth Rate (2018-2029) & (US$ Million) Figure 42. Malaysia Non-prescription Mouthrinse Revenue Growth Rate (2018-2029) & (US$ Million) Figure 43. Philippines Non-prescription Mouthrinse Revenue Growth Rate (2018-2029) & (US$ Million) Figure 44. Latin America Non-prescription Mouthrinse Sales Market Share by Country (2018-2029) Figure 45. Latin America Non-prescription Mouthrinse Revenue Market Share by Country (2018-2029) Figure 46. Mexico Non-prescription Mouthrinse Revenue Growth Rate (2018-2029) & (US$ Million) Figure 47. Brazil Non-prescription Mouthrinse Revenue Growth Rate (2018-2029) & (US$ Million) Figure 48. Argentina Non-prescription Mouthrinse Revenue Growth Rate (2018-2029) & (US$ Million) Figure 49. Middle East & Africa Non-prescription Mouthrinse Sales Market Share by Country (2018-2029) Figure 50. Middle East & Africa Non-prescription Mouthrinse Revenue Market Share by Country (2018-2029) Figure 51. Turkey Non-prescription Mouthrinse Revenue Growth Rate (2018-2029) & (US$ Million) Figure 52. Saudi Arabia Non-prescription Mouthrinse Revenue Growth Rate (2018-2029) & (US$ Million) Figure 53. U.A.E Non-prescription Mouthrinse Revenue Growth Rate (2018-2029) & (US$ Million) Figure 54. Global Sales Market Share of Non-prescription Mouthrinse by Type (2018-2029) Figure 55. Global Revenue Market Share of Non-prescription Mouthrinse by Type (2018-2029) Figure 56. Global Non-prescription Mouthrinse Price (US$/Unit) by Type (2018-2029) Figure 57. Global Sales Market Share of Non-prescription Mouthrinse by Application (2018-2029) Figure 58. Global Revenue Market Share of Non-prescription Mouthrinse by Application (2018-2029) Figure 59. Global Non-prescription Mouthrinse Price (US$/Unit) by Application (2018-2029) Figure 60. Non-prescription Mouthrinse Value Chain Figure 61. Non-prescription Mouthrinse Production Process Figure 62. Channels of Distribution (Direct Vs Distribution) Figure 63. Distributors Profiles Figure 64. Bottom-up and Top-down Approaches for This Report Figure 65. Data Triangulation Figure 66. Key Executives Interviewed

Johnson & Johnson Sunstar P&G Lion Colgate-Palmolive Unilever Church & Dwight PIERAS CO GSK Caldwell Consumer Health Weleda Dentyl Active Kao Corporation NYSCPS WEIMEIZI (GUANGDONG) CO.